Book your FREE* Doctor Consultation
With first injection same day*
1630 South Lemay Ave Suite 3
Fort Collins, CO 80525
970-657-2036
What is Compounded Semaglutide/ B12?
Our Compounded Semaglutide is a Glucagon- like peptide-1, administered through weekly injections. GLP-1 is a hormone that increases insulin production, which lowers blood sugar levels while inhibiting glucagon secretion, which raises blood sugar, reduces appetite and energy intake, all while delaying gastric emptying.
How does it work?
Compounded Semaglutide/L Carnatine/B12 works by:
-Slowing down the movement of food through the intestine, enabling people to feel full for a longer period.
-Helping to lower blood sugar by making insulin work better, thus reducing the impact of insulin, which is a hormone that stimulates obesity.
-Suppressing the part of the brain that drives food craving.
This results in a very powerful and lasting appetite suppression for most clients in addition to improving blood sugar levels.
​
Cardio protection
-Improves microvascular function
-Improves lipids
-Reduces blood pressure
​
Neuro-protective
-Decreases inflammation
-Improves memory
​
Endocrine
-Improves insulin sensitivity
-Reduces fatty liver
​
Metabolism
-Reduces appetite
-Promotes white to brown fat conversion
Other benefits
may include:
Inquire about Compounded Tirezepatide
We offer Compounded Tirzeptide as a second injectable option.
Semaglutide and its successors MUST be paired with an insulin-controlled lifestyle (i.e. high protein intake, resistance & cardiovascular training, proper sleep, nutritious whole foods, etc.) if you desire to achieve successful results and eventually stop injections without body fat rebound weight gain.
Our weight loss program begins with a consultation with our Medical Director. Once approved, our caring and knowledgeable nurses will meet with you weekly to safely administer injections and to give you support to help you reach your weight loss goals.
We're with you every step of the way!
Warning!
In rodents, both caused dose dependent, treatment duration dependent, thyroid C-cell tumors at chemically relevant-exposures. It is unknown whether Semaglutide/Tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma in humans.
They are both contraindicated in patients with a personal and/or family history of:
-
Medullary thyroid cancer
-
Acute pancreatitis
-
Acute gall bladder disease
-
Hypoglycemia
-
Acute kidney injury